STAMBPL1 activates the GRHL3/HIF1A/VEGFA axis through interaction with FOXO1 to promote angiogenesis in triple-negative breast cancer
In the clinic, anti-tumor angiogenesis is commonly employed for treating recurrent, metastatic, drug-resistant triple-negative, and advanced breast cancer. Our previous research revealed that the deubiquitinase STAMBPL1 enhances the stability of MKP-1, thereby promoting cisplatin resistance in breas...
Saved in:
| Main Authors: | Huan Fang, Huichun Liang, Chuanyu Yang, Dewei Jiang, Qianmei Luo, Wen-Ming Cao, Huifeng Zhang, Ceshi Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
eLife Sciences Publications Ltd
2025-04-01
|
| Series: | eLife |
| Subjects: | |
| Online Access: | https://elifesciences.org/articles/102433 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress and perspectives on BMP9-ID1 activation of HIF-1α and VEGFA to promote angiogenesis in hepatic alveolar echinococcosis
by: Fei Ke, et al.
Published: (2024-11-01) -
PKN2 Inhibits VEGFA and bFGF‐Mediated Angiogenesis by Targeting HIF‐1α in Colon Cancer
by: Yun Zhu, et al.
Published: (2025-07-01) -
Angiogenesis Induced by HIF1α and VEGF as Pathophysiological Cause of Glaucoma
by: Burim Neziri, et al.
Published: (2025-06-01) -
Cell-type specific effects of the long non-coding RNA HIF1A-AS3 on HIF1A expression in kidney cells
by: Simone Reichelt-Wurm, et al.
Published: (2025-07-01) -
Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma
by: Barbara Montico, et al.
Published: (2025-02-01)